Investigator Site 0070038

Nizhny Novgorod

0 studies enrolling now · 2 studies all time

What they study most

Primary Immune Thrombocytopenia

Studies at this site

• A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia — Completed